HCPCS Level II code G0399 covers unattended home sleep testing (HST) performed with a Type III portable monitor that records at least four channels, including respiratory movement/airflow, ECG/heart rate, and oxygen saturation. This code is widely used in the evaluation of suspected sleep-disordered breathing and supports ambulatory diagnostic workflows that reduce reliance on in-lab polysomnography. Nationally, home sleep testing is an important pathway for timely diagnosis and triage for sleep apnea and related conditions.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find information on coding context, common billing modifiers, clinical service setting, and how this code fits into outpatient sleep diagnostics. The publication summarizes benchmarking considerations, typical payer coverage patterns, and operational implications for clinicians and billing teams. Where specific payer policy details or utilization benchmarks are not present in the input, the report notes that data is not available in the input.

This summary equips clinicians, practice managers, and reimbursement specialists with a concise reference to HCPCS Level II code G0399’s clinical role, expected site-of-service, and the payer landscape relevant to national billing and coding practice.